International Journal of Bipolar Disorders (Jul 2019)

Clinical use of lithium salts: guide for users and prescribers

  • Leonardo Tondo,
  • Martin Alda,
  • Michael Bauer,
  • Veerle Bergink,
  • Paul Grof,
  • Tomas Hajek,
  • Ute Lewitka,
  • Rasmus W. Licht,
  • Mirko Manchia,
  • Bruno Müller-Oerlinghausen,
  • René E. Nielsen,
  • Marylou Selo,
  • Christian Simhandl,
  • Ross J. Baldessarini,
  • for the International Group for Studies of Lithium (IGSLi)

DOI
https://doi.org/10.1186/s40345-019-0151-2
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background Lithium has been used clinically for 70 years, mainly to treat bipolar disorder. Competing treatments and exaggerated impressions about complexity and risks of lithium treatment have led to its declining use in some countries, encouraging this update about its safe clinical use. We conducted a nonsystematic review of recent research reports and developed consensus among international experts on the use of lithium to treat major mood disorders, aiming for a simple but authoritative guide for patients and prescribers. Main text We summarized recommendations concerning safe clinical use of lithium salts to treat major mood disorders, including indications, dosing, clinical monitoring, adverse effects and use in specific circumstances including during pregnancy and for the elderly. Conclusions Lithium continues as the standard and most extensively evaluated treatment for bipolar disorder, especially for long-term prophylaxis.

Keywords